NICE and the FDA working together

NICE

14 December 2016 - NICE and the US FDA are working closely to help developers of medical devices, diagnostics, and similar technologies gather the best evidence to demonstrate clinical effectiveness of their products. The aim is to speed up patients’ access to the best new technologies.

Once they get approval from safety regulators, medical technology companies need to demonstrate the value of their product to the organisations who pay for healthcare – in the UK that is usually the NHS, whereas insurers mostly pay for technologies in the United States.

The products could be diagnostic tests or medical devices.

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Collaboration